Showing 1 – 7 of 7
Relevance | Newest | Oldest |
  • JAMA Oncology Brief Report
    April 25, 2024

    Omission of Axillary Dissection Following Nodal Downstaging With Neoadjuvant Chemotherapy

    Giacomo聽Montagna,听惭顿, MPH; Mary M.听Mrdutt,听惭顿, MS; Susie X.听Sun,听惭顿; Callie聽Hlavin,听惭顿, MPH; Emilia J.听Diego,听惭顿; Stephanie M.听Wong,听惭顿, MPH; Andrea V.听Barrio,听惭顿; Astrid Botty聽van den Bruele,听惭顿; Neslihan聽Cabioglu,听惭顿, PhD; Varadan聽Sevilimedu,聽MBBS, DrPH; Laura H.听Rosenberger,听惭顿, MS; E. Shelley聽Hwang,听惭顿, MPH; Abigail聽Ingham,聽MBchB; B盲rbel聽Papassotiropoulos,听惭顿; Bich Doan聽Nguyen-Str盲uli,听惭顿; Christian聽Kurzeder,听惭顿; Danilo D铆az聽Aybar,听惭顿; Denise聽Vorburger,听惭顿; Dieter Michael聽Matlac,听惭顿; Edvin聽Ostapenko,听惭顿; Fabian聽Riedel,听惭顿; Florian聽Fitzal,听惭顿; Francesco聽Meani,听惭顿; Franziska聽Fick,听惭顿; Jacqueline聽Sagasser,听惭顿; J枚rg聽Heil,听惭顿, PhD; Hasan聽Karanl谋k,听惭顿; Konstantin J.听Dedes,听惭顿; Laszlo聽Romics,听惭顿, PhD; Maggie聽Banys-Paluchowski,听惭顿, PhD; Mahmut聽Muslumanoglu,听惭顿; Maria Del Rosario Cueva聽Perez,听惭顿; Marcelo Ch谩vez聽D铆az,听惭顿; Martin聽Heidinger,听惭顿; Mathias K.听Fehr,听惭顿; Mattea聽Reinisch,听惭顿; Mustafa聽Tukenmez,听惭顿; Nadia聽Maggi,听惭顿; Nicola聽Rocco,听惭顿, PhD; Nina聽Ditsch,听惭顿, PhD; Oreste Davide聽Gentilini,听惭顿; Regis R.听Paulinelli,听惭顿, PhD; Sebasti谩n Sol茅聽Zarhi,听惭顿; Sherko聽Kuemmel,听惭顿, PhD; Simona聽Bruzas,听惭顿; Simona聽di Lascio,听惭顿; Tamara K.听Parissenti,听惭顿; Tanya L.听Hoskin,聽MS; Uwe聽G眉th,听惭顿; Valentina聽Ovalle,听惭顿; Christoph聽Tausch,听惭顿; Henry M.听Kuerer,听惭顿, PhD; Abigail S.听Caudle,听惭顿; Jean-Francois聽Boileau,听惭顿, MSc; Judy C.听Boughey,听惭顿; Thorsten聽K眉hn,听惭顿, PhD; Monica聽Morrow,听惭顿; Walter P.听Weber,听惭顿
    Abstract Full Text
    online first
    JAMA Oncol. 2024; 10.1001/jamaoncol.2024.0578

    This cohort study examines oncological outcomes after sentinel lymph node biopsy with dual-tracer mapping or targeted axillary dissection.

  • JAMA Surgery Original Investigation
    March 27, 2024

    Quality of Life After Axillary Lymph Node Dissection Among Racial and Ethnic Minority Women

    Danielle R.听Heller,听惭顿, MHS; Bayley聽Axelrod,聽BS, MHA; Varadan聽Sevilimedu,聽MBBS, PhD; Monica聽Morrow,听惭顿; Babak J.听Mehrara,听惭顿; Andrea V.听Barrio,听惭顿
    Abstract Full Text
    online first
    JAMA Surg. 2024; 10.1001/jamasurg.2024.0118

    This cohort study examines the association between race and ethnicity and long-term quality of life after unilateral axillary lymph node dissection in women with breast cancer.

  • JAMA Surgery Original Investigation
    July 12, 2023

    Feasibility and Clinical Utility of Prediction Models for Breast Cancer鈥揜elated Lymphedema Incorporating Racial Differences in Disease Incidence

    Danielle H.听Rochlin,听惭顿; Andrea V.听Barrio,听惭顿; Sarah聽McLaughlin,听惭顿; Kimberly J.听Van Zee,聽MS, MD; Jack F.听Woods,听惭顿; Joseph H.听Dayan,听惭顿, MBA; Michelle R.听Coriddi,听惭顿; Leslie A.听McGrath,聽NP; Emily A.听Bloomfield,聽NP; Lillian聽Boe,聽MS, PhD; Babak J.听Mehrara,听惭顿
    Abstract Full Text
    JAMA Surg. 2023; 158(9):954-964. 10.1001/jamasurg.2023.2414

    This prognostic study evaluates prediction models for breast cancer鈥搑elated lymphedema (BCRL) that can be used to estimate preoperative or postoperative risk.

  • JAMA Oncology Brief Report
    June 9, 2022

    Risk Factors and Racial and Ethnic Disparities in Patients With Breast Cancer鈥揜elated Lymphedema

    Giacomo聽Montagna,听惭顿, MPH; Jennifer聽Zhang,听惭顿; Varadan聽Sevilimedu,聽MBSS, DrPH; Jillian聽Charyn,聽BS; Kelly聽Abbate,聽BS; Ethan A.听Gomez,聽BS; Babak聽Mehrara,听惭顿; Monica聽Morrow,听惭顿; Andrea V.听Barrio,听惭顿
    Abstract Full Text
    free access
    JAMA Oncol. 2022; 8(8):1195-1200. 10.1001/jamaoncol.2022.1628

    This cohort study evaluate rates and risk factors associated with breast cancer鈥搑elated lymphedema in patients treated with axillary lymph node dissection.

  • JAMA Oncology Comment & Response
    May 12, 2022

    Is Regional Nodal Radiotherapy Necessary for Patients With cN1 and ypN0 Breast Cancer After Neoadjuvant Chemotherapy?鈥擱eply

    Andrea V.听Barrio,听惭顿; Giacomo聽Montagna,听惭顿, MPH; Monica聽Morrow,听惭顿
    Abstract Full Text
    JAMA Oncol. 2022; 8(6):942-943. 10.1001/jamaoncol.2022.0316
  • JAMA Oncology Brief Report
    October 7, 2021

    Nodal Recurrence in Patients With Node-Positive Breast Cancer Treated With Sentinel Node Biopsy Alone After Neoadjuvant Chemotherapy鈥擜 Rare Event

    Andrea V.听Barrio,听惭顿; Giacomo聽Montagna,听惭顿, MPH; Anita聽Mamtani,听惭顿; Varadan聽Sevilimedu,聽MBBS, DrPH; Marcia聽Edelweiss,听惭顿; Deborah聽Capko,听惭顿; Hiram S.听Cody聽III,听惭顿; Mahmoud聽El-Tamer,听惭顿; Mary L.听Gemignani,聽MPH, MD; Alexandra聽Heerdt,听惭顿; Laurie聽Kirstein,听惭顿; Tracy-Ann聽Moo,听惭顿; Melissa聽Pilewskie,听惭顿; George聽Plitas,听惭顿; Virgilio聽Sacchini,听惭顿; Lisa聽Sclafani,听惭顿; Audree聽Tadros,听惭顿; Kimberly J.听Van Zee,聽MS, MD; Monica聽Morrow,听惭顿
    Abstract Full Text
    free access
    JAMA Oncol. 2021; 7(12):1851-1855. 10.1001/jamaoncol.2021.4394

    This cohort study examines nodal recurrence rates in patients with clinically node-positive cancer treated with sentinel lymph node biopsy alone after neoadjuvant chemotherapy.

  • JAMA Oncology Comment & Response
    March 1, 2016

    Treatment and Long-Term Risks for Patients With a Diagnosis of Ductal Carcinoma In Situ

    Kimberly J.听Van Zee,听惭顿; Andrea V.听Barrio,听惭顿; Julia聽Tchou,听惭顿; for the Society of Surgical Oncology Breast Disease Site Work Group
    Abstract Full Text
    JAMA Oncol. 2016; 2(3):397-398. 10.1001/jamaoncol.2015.4860